“THE POTENTIAL OF CHIMERIC ANTIGEN RECEPTOR T CELL (CART-T CELL) TARGETTING PROSTATE-SPECIFIC MEMRANE ANTIGEN (PSMA) MODIFIED BY CRISPR/CAS9 AS PROSTATE CANCER THERAPY” (2021) JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 9(1), pp. 23–37. doi:10.53366/jimki.v9i1.321.